In some studies, MIP-1b might be a promising biomarker of SLE underlying its ability to predict active lupus, and circulating MIP-1b levels were higher in patients with SLE than in healthy controls [44, 45]. The gene discussed is CCL4; the disease is systemic lupus erythematosus.